Ovsyannikova Inna G, Vierkant Robert A, Poland Gregory A
Mayo Vaccine Research Group, Guggenheim 611C, 200 First Street SW, Rochester, MN 55905, USA.
Vaccine. 2006 Jun 19;24(25):5381-9. doi: 10.1016/j.vaccine.2006.04.034. Epub 2006 May 3.
We studied the association between class II human leukocyte antigen (HLA)-DRB10301 presented measles virus (MV) peptide-specific cytokine responses and DQB1 and DPB1 alleles among 313 individuals who received two doses of measles-mumps-rubella-II vaccine. The overall median IFN-gamma secretion levels (first and third quartiles) for the 19-amino acid MV phosphoprotein (MV-P)- and 14-amino acid MV nucleoprotein (MV-N)-derived peptides were 27.7 pg/ml (1.8, 109.4) and 1.9 pg/ml (-6.2, 13.0), respectively; median IL-4 secretion levels were -0.6 pg/ml (-7.1, 6.2) and 2.4 pg/ml (-3.2, 9.3), respectively. Primary statistical analyses were adjusted for previously identified DRB1 associations. A marginally significant increase in the frequency of the DQB10604 (p=0.02) allele was found among subjects who demonstrated detectable IL-4 levels to the MV-P peptide. Further, DPB10201 (p=0.02) and DPB11301 (p=0.09) alleles provided suggestive evidence of an association with MV-P-induced IL-4 secretion. Examination of IFN-gamma responses to MV-P and MV-N indicated that none of the individual alleles of the DQB1 and DPB1 loci were associated with peptide-induced T cell response. An increase in the frequency of DPB10501 (p=0.01) was found among subjects who failed to produce MV-N peptide-specific IL-4 responses. These data further confirm that HLA-DRB1 alleles are the major restriction molecules for MV-P and MV-N measles virus antigen presentation to T cells. We speculate that MV-P and MV-N peptides derived from DRB10301 could potentially be recognized in association with different HLA molecules, including DQB1 and DPB1; however, statistical adjustments for the effect of HLA-DR locus could potentially alter these genetic relationships. This concept provides important information supporting the use of promiscuous peptides in a peptide-based vaccine approach.
我们研究了313名接种两剂麻疹-腮腺炎-风疹-Ⅱ疫苗的个体中,Ⅱ类人类白细胞抗原(HLA)-DRB10301呈递的麻疹病毒(MV)肽特异性细胞因子反应与DQB1和DPB1等位基因之间的关联。19个氨基酸的MV磷蛋白(MV-P)和14个氨基酸的MV核蛋白(MV-N)衍生肽的总体中位干扰素-γ分泌水平(第一和第三四分位数)分别为27.7 pg/ml(1.8,109.4)和1.9 pg/ml(-6.2,13.0);中位白细胞介素-4分泌水平分别为-0.6 pg/ml(-7.1,6.2)和2.4 pg/ml(-3.2,9.3)。主要统计分析针对先前确定的DRB1关联进行了调整。在对MV-P肽表现出可检测白细胞介素-4水平的受试者中,发现DQB10604等位基因频率有边缘性显著增加(p=0.02)。此外,DPB10201(p=0.02)和DPB11301(p=0.09)等位基因提供了与MV-P诱导的白细胞介素-4分泌相关联的提示性证据。对MV-P和MV-N的干扰素-γ反应检查表明,DQB1和DPB1基因座的单个等位基因均与肽诱导型T细胞反应无关。在未能产生MV-N肽特异性白细胞介素-4反应的受试者中,发现DPB10501频率增加(p=0.01)。这些数据进一步证实,HLA-DRB1等位基因是MV-P和MV-N麻疹病毒抗原呈递给T细胞的主要限制分子。我们推测,源自DRB10301的MV-P和MV-N肽可能与包括DQB1和DPB1在内的不同HLA分子相关联而被识别;然而,对HLA-DR基因座效应的统计调整可能会改变这些遗传关系。这一概念为基于肽的疫苗方法中使用混杂肽提供了重要信息支持。